Inclusion Criteria:~* Diagnosis of probable Alzheimer Disease (AD) with documented evidence of progression of
disease~* Mini Mental State Examination (MMSE) score of 21-26, inclusive~* Clinical Dementia Rating global
score of 0.5 or 1~* Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-cog14) of 10 or more~*
Brain magnetic resonance imaging (MRI) consistent with the diagnosis of probable AD~* Concurrent use of
cholinesterase inhibitor or memantine with stable dose for at least 2 months prior to screening~* Hemoglobin
A1c (HbA1c) 6.5% - 9.5%, inclusive~* Caregiver willing to participate and be able to attend clinic visits with
patient~* Ability to ingest oral medications~
